Carmel, Milazzo & DiChiara LLP Represents Co-Diagnostics, Inc. (NASDAQ: CODX) in $7 Million Initial Public Offering (IPO)

Press Release – New York, NY – July 13, 2017 –  Securities and corporate law firm Carmel, Milazzo & DiChiara LLP announced today that it has represented Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests, in a $7 Million Initial Public Offering on […]